TY - JOUR
T1 - The efficacy of the Eustachian Tube Dysfunction Questionnaire (ETDQ-7) for patulous Eustachian tube patient
AU - Ikeda, Ryoukichi
AU - Kikuchi, Toshiaki
AU - Miyazaki, Hiromitsu
AU - Hidaka, Hiroshi
AU - Kawase, Tetsuaki
AU - Katori, Yukio
AU - Kobayashi, Toshimitsu
N1 - Funding Information:
This work was supported by JSPS KAKENHI grant number 15K20175 and the Project Promoting Clinical Trials for Development of New Drugs and Medical Devices (Japan Medical Association) from Japan Agency for Medical Research and Development, AMED.
Publisher Copyright:
© 2017 Acta Oto-Laryngologica AB (Ltd).
PY - 2018/1/2
Y1 - 2018/1/2
N2 - Objective: To assess the efficacy of the Eustachian Tube Dysfunction Questionnaire (ETDQ-7) for patulous Eustachian tube (PET) patients. Methods: A prospective survey of medical records identified 36 patients and 47 ears with PET, and 15 patients and 15 ears as control. The ETDQ-7, patulous Eustachian tube handicap inventory-10 (PHI-10) and Likert scale were evaluated. PET patients were divided into two groups based on severity of symptoms using the PHI score. Results: The Cronbach α value of the PET group was 0.765. The average total score of the ETDQ-7 in the control group was 7.6 ± 1.1 and 22.5 ± 10.0 in the PET group (p <.01). No correlation was found between ETDQ-7 and Likert scale (r = 0.248, p =.09). The average total score of the ETDQ-7 in the mild or moderate PET group was 19.9 ± 9.0 and 25.3 ± 11.1 in the severe PET group and this was not statistically different (p =.08). Conclusion: The highest ETDQ-7 score was also observed in PET patients and in ET dysfunction patients. These findings necessitate careful discrimination between ET dysfunction and PET in balloon dilation Eustachian tuboplasty (BET) based on ETDQ-7.
AB - Objective: To assess the efficacy of the Eustachian Tube Dysfunction Questionnaire (ETDQ-7) for patulous Eustachian tube (PET) patients. Methods: A prospective survey of medical records identified 36 patients and 47 ears with PET, and 15 patients and 15 ears as control. The ETDQ-7, patulous Eustachian tube handicap inventory-10 (PHI-10) and Likert scale were evaluated. PET patients were divided into two groups based on severity of symptoms using the PHI score. Results: The Cronbach α value of the PET group was 0.765. The average total score of the ETDQ-7 in the control group was 7.6 ± 1.1 and 22.5 ± 10.0 in the PET group (p <.01). No correlation was found between ETDQ-7 and Likert scale (r = 0.248, p =.09). The average total score of the ETDQ-7 in the mild or moderate PET group was 19.9 ± 9.0 and 25.3 ± 11.1 in the severe PET group and this was not statistically different (p =.08). Conclusion: The highest ETDQ-7 score was also observed in PET patients and in ET dysfunction patients. These findings necessitate careful discrimination between ET dysfunction and PET in balloon dilation Eustachian tuboplasty (BET) based on ETDQ-7.
KW - ETDQ-7
KW - Eustachian tube dysfunction
KW - middle ear
KW - Patulous Eustachian tube
UR - http://www.scopus.com/inward/record.url?scp=85029456475&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85029456475&partnerID=8YFLogxK
U2 - 10.1080/00016489.2017.1366053
DO - 10.1080/00016489.2017.1366053
M3 - Article
C2 - 28880712
AN - SCOPUS:85029456475
SN - 0001-6489
VL - 138
SP - 6
EP - 9
JO - Acta Oto-Laryngologica
JF - Acta Oto-Laryngologica
IS - 1
ER -